Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
sábado, 30 de octubre de 2010
Pregnancy outcome affected by immune system genes
Contact: Karen Honey
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
Pregnancy outcome affected by immune system genes
A team of researchers, led by Ashley Moffett, at the University of Cambridge, United Kingdom, has shed new light on genetic factors that increase susceptibility to and provide protection from common disorders of pregnancy, specifically recurrent miscarriage, preeclampsia, and fetal growth restriction.
A key step in the initiation of a successful pregnancy is the invasion of the lining of the uterus by fetal cells known as trophoblasts, which become the main cell type of the placenta. Recurrent miscarriage, preeclampsia, and fetal growth restriction are thought to result from inadequate trophoblast invasion of the uterus lining. Interactions between maternal cells known as uterine NK cells and fetal trophoblasts — specifically interactions between HLA-C molecules on the fetal trophoblasts and KIRs on the maternal uterine NK cells — are key to determining the extent of trophoblast invasion. Previous data from Moffett's lab indicated that a particular combination of fetal HLA-C and maternal KIR was associated with increased risk of preeclampsia. In this study, the team has extended this correlation to recurrent miscarriage and fetal growth restriction. Furthermore, they have determined that the presence of other maternal KIRs that combine with the same HLA-C molecule provides protection against the same common disorders of pregnancy.
In an accompanying commentary, Peter Parham and Lisbeth Guethlein, at Stanford University, discuss the importance of these data and how they might explain distinct immune system gene expression patterns in different populations.
###
TITLE: Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2
AUTHOR CONTACT:
Ashley Moffett
University of Cambridge, Cambridge, United Kingdom.
Phone: 44.1223.333729; Fax: 44.1223.765065; E-mail: am485@cam.ac.uk.
View this article at: http://www.jci.org/articles/view/43998?key=cfb4e33703c44a22516f
ACCOMPANYING COMMENTARY
TITLE: Pregnancy immunogenetics: NK cell education in the womb?
AUTHOR CONTACT:
Peter Parham
Stanford University, Stanford, California, USA.
Phone: 650.723.7456; Fax: 650.723.8464; E-mail: peropa@stanford.edu.
View this article at: http://www.jci.org/articles/view/44559?key=a12c31691937fa2e1d6b
Pregnancy outcome affected by immune system genes
No hay comentarios:
Publicar un comentario